Venoarterial ECMO (Extracorporeal Membrane Oxygenation)
A (Venoarterial) ECMO (Extracorporeal Membrane Oxygenation) refers to a type of mechanical circulatory support for patients with cardiac or pulmonary insufficiency. In patients with ischemic cardiomyopathy, the indication for VA ECMO includes decreased ventricular functions. Below is the information on ischemic cardiomyopathy, and VA ECMO.

IschemicIschemic Cardiomyopathy:

Ischemic cardiomyopathy is a condition wherein the heart is unable to pump due to a decrease in blood supply to the heart muscles. The decrease in the supply of blood can be due to coronary artery disease or heart attack. Ischemic cardiomyopathy can lead to heart failure.

VA ECMO In Ischemic Cardiomyopathy:

Support For Cardiac Pumping Function Ischemic cardiomyopathy patients with significantly decreased cardiac function resistant to treatment can be managed by the Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO) for circulatory and oxygenation support to the whole body, giving the heart rest. A VA ECMO can be considered for circulatory and oxygenation support for patients presenting with ischemic cardiomyopathy. It can also be considered as a bridge to the recovery or other treatments for ischemic cardiomyopathy, including heart transplant.

Indications for VA ECMO for Ischemic Cardiomyopathy:

1. Refractory cardiogenic shock due to decreased cardiac function secondary to ischemic cardiomyopathy

2. Cardiac arrest

3. As a bridge to the recovery or heart transplant

Benefits:

VA ECMO can provide circulatory and oxygenation support for patients with decreased cardiac function secondary to ischemic cardiomyopathy. VA ECMO can be considered as a treatment option for patients with ischemic cardiomyopathy as a bridge to heart transplant. Patients presenting with refractory cardiogenic shock and cardiac arrest can also be considered for VA ECMO.

Complications:

1. Bleeding due to anticoagulation

2. Infection

3. End-organ injury

Prognosis: The prognosis of patients with ischemic cardiomyopathy mainly depends on the severity of the disease, patient’s treatment response, and the availability of other treatment options, such as a heart transplant. Generally, VA ECMO can be considered as a life-saving procedure for patients with ischemic cardiomyopathy. However, it is not seen as a definitive treatment. To conclude, the prognosis of ischemic cardiomyopathy patients, including those supported by VA ECMO, is generally poor.

In summary, VA ECMO can be considered for the treatment of ischemic cardiomyopathy patients with significantly reduced cardiac function resistant to conventional treatment. VA ECMO can provide circulatory and oxygenation support for such patients for the time being or as a bridge to other treatment options, including a heart transplant. However, it is only a temporizing procedure, and the prognosis of the patients with ischemic cardiomyopathy and VA ECMO is generally poor.

VA ECMO for Dilated Cardiomyopathy:

Venoarterial (VA) Extracorporeal Membrane Oxygenation (ECMO) is indicated for dilated cardiomyopathy (DCM) – although the nuances of the indication and treatment are slightly different. Below, you can find information on VA ECMO for dilated cardiomyopathy.

What is Dilated Cardiomyopathy (DCM)?

Dilated cardiomyopathy is a type of cardiomyopathy that involves enlarged heart chambers and impaired contraction of the heart muscle. There are several causes of dilated cardiomyopathy, including:

• Genetics

• Viral infections

• Alcohol abuse

• Autoimmune diseases

• Pregnancy/peripartum cardiomyopathy

• Idiopathic (this means that the cause of DCM is unknown)

Role of VA ECMO in Dilated Cardiomyopathy (DCM):

VA ECMO in patients with dilated cardiomyopathy is indicated in cardiogenic shock, acute decompensation of heart failure or cardiac arrest as a temporizing measure to allow the heart to recover while receiving treatment, to support the circulatory system until the heart transplant, or to recover ventricular function.

1. When is VA ECMO used in dilated cardiomyopathy?

Cardiogenic shock: cardiogenic shock is a condition caused by the inability of the heart to pump blood, resulting in decreased blood flow throughout the body. Cardiogenic shock leads to decreased blood pressure, inadequate tissue perfusion, and multi-organ failure.

Acute decompensated heart failure: Dilated cardiomyopathy often leads to acute decompensated heart failure. Acute decompensated heart failure is a condition characterized by the failure of the heart to adequately pump blood, leading to fluid retention, dyspnea, and other related symptoms.

Cardiac arrest: In the context of cardiac arrest, VA ECMO can offer temporary circulatory and oxygenation support to patients presenting with refractory rhythms following conventional CPR.

Bridge to recovery: VA ECMO can be considered for patients with dilated cardiomyopathy who are potential candidates for heart recovery.

Bridge to heart transplant: VA ECMO can be used as a bridge to heart transplant in patients with dilated cardiomyopathy who are not potential candidates for heart recovery.

2. How does VA ECMO work in dilated cardiomyopathy?

The procedure of VA ECMO connects venous and arterial blood circulation, which reroutes the blood from the veins to the lungs to be oxygenated and then redirected back to the arteries; thus, VA ECMO can reduce the burden on the heart.

3. Benefits of VA ECMO in dilated cardiomyopathy:

Hemodynamic stabilization: VA ECMO can help to stabilize the patient’s circulatory system in cases of severely reduced cardiac output.

Cardiac rest and recovery: VA ECMO can give the heart rest and allow it to recover, which is critically important for patients with dilated cardiomyopathy who can benefit from reducing the workload of the heart.

Bridge to other treatments: VA ECMO can serve as a bridge to other treatment options for patients with dilated cardiomyopathy, such as heart transplant or VADs (ventricular assist devices).

Potential for heart recovery: VA ECMO can be a beneficial option for patients with dilated cardiomyopathy and potential for heart recovery.

4. Risks and complications of VA ECMO:

Bleeding: One of the significant risks of VA ECMO is the risk of bleeding, especially intracranial hemorrhage. This complication is related to the need for VA ECMO patients to be anticoagulated to prevent clotting of the VA ECMO circuit.

Infection: Another risk of VA ECMO is the risk of infection, especially since VA ECMO requires venous access for cannulation, which can lead to infection.

Organ failure: Although VA ECMO is a life-saving procedure, it is also associated with the risk of multiple organ failure, especially renal failure.

Vascular injury: Another risk of VA ECMO is vascular injury, which can happen due to the placement of large catheters in the veins and arteries during the VA ECMO procedure.

Mechanical failure: Another risk of VA ECMO is mechanical failure of the machine, which can lead to serious complications and even death.

Heparin-induced thrombocytopenia: Another risk of VA ECMO is heparin-induced thrombocytopenia, a condition in which patients develop low platelet counts due to heparin, an anticoagulant medication used to prevent clotting of the VA ECMO circuit.

5. Prognosis and outcomes of VA ECMO for DCM:

Recovery: Some patients with dilated cardiomyopathy can recover partially or completely, returning to a normal or near-normal life. With VA ECMO, patients have a chance to recover their heart function. In general, the prognosis of dilated cardiomyopathy largely depends on the etiology; viral infections and myocarditis are generally associated with a worse prognosis, whereas cardiomyopathy due to toxic insults and other reversible causes is associated with a better prognosis.

Heart transplant: For patients who are not potential candidates for heart recovery, VA ECMO can be a bridge to transplant. In general, the prognosis of patients who undergo heart transplant for dilated cardiomyopathy also largely depends on various factors, including donor-recipient compatibility.

Overall survival: In general, the survival of patients with dilated cardiomyopathy who are placed on ventricular assist devices largely depends on various factors, including the severity of the underlying condition and the effectiveness of the treatment.

6. Challenges specific to DCM:

Chronicity: Dilated cardiomyopathy is often a chronic condition, unlike other types of cardiomyopathy. For this reason, patients with dilated cardiomyopathy may need long-term mechanical circulatory support, which can be associated with many complications.

Reduced ventricular function: Patients with dilated cardiomyopathy often present with severely reduced ventricular function, which can make VA ECMO a more challenging procedure.

High risk of remodeling: Dilated cardiomyopathy is often associated with a high risk of remodeling and deterioration of heart function.